Data / Drug companies / Tom Ford Beauty Dist
Tom Ford Beauty Dist: 6 products in the FDA NDC directory, labeler code 76398
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Tom Ford Beauty Dist (labeler code 76398) lists 6 products in the FDA National Drug Code Directory, covering 2 finished drugs by generic name. By type: 3 drugs for further processing, 3 over the counter drugs. Its main marketing category is drugs for further processing. The newest product started marketing on December 6, 2024.
The request: Watch Tom Ford Beauty Dist (FDA labeler code 76398): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 76398
- Products in commercial distribution
- 6
- Packages
- 6
- Finished drugs by generic name
- 2
- Prescription products
- 0
- Over the counter products
- 3
- Flagged as original packager
- 3 of 3 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- October 10, 2019
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Drugs for further processing | 3 | 50% |
| Over the counter monograph drugs | 3 | 50% |
Products by type
| Type | Products | Share |
|---|---|---|
| Drugs for further processing | 3 | 50% |
| Over the counter drugs | 3 | 50% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Ensulizole, octinoxate, octisalate, and zinc oxide | 2 | 3 |
| Octinoxate,octisalate,zinc oxide | 1 | 2 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 2 | 33.3% |
| Emulsion | 2 | 33.3% |
| Liquid | 2 | 33.3% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Tom ford architecture radiance hydrating foundation broad spectrum spf 50 | 76398-015 | Emulsion | Over the counter monograph drugs | December 6, 2024 |
| Tom ford architecture radiance hydrating foundation broad spectrum spf 50 | 76398-902 | Emulsion | Drugs for further processing | December 4, 2024 |
| Octinoxate,octisalate,zinc oxide | 76398-901 | Cream | Drugs for further processing | January 18, 2023 |
| Ensulizole, octinoxate, octisalate, and zinc oxide | 76398-900 | Liquid | Drugs for further processing | January 18, 2023 |
| SHADE and ILLUMINATE SOFT RAD PRMR SPF | 76398-013 | Cream | Over the counter monograph drugs | October 14, 2022 |
| Tom ford shade and illuminate soft radiance foundation broad spectrum spf 50 | 76398-010 | Liquid | Over the counter monograph drugs | October 10, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.